Trial Profile
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2019
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Diagnostic use
- 14 Jun 2018 Status changed from recruiting to discontinued.
- 01 Jun 2017 New trial record